Procter & Gamble Company (The) $PG Shares Sold by Investment House LLC

Investment House LLC decreased its holdings in Procter & Gamble Company (The) (NYSE:PG) by 39.6% in the third quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 4,762 shares of the company’s stock after selling 3,126 shares during the quarter. Investment House LLC’s holdings in Procter & Gamble were worth $692,000 as of its most recent filing with the SEC.

Other hedge funds also recently made changes to their positions in the company. JSF Financial LLC boosted its stake in Procter & Gamble by 17.1% in the 3rd quarter. JSF Financial LLC now owns 5,841 shares of the company’s stock valued at $849,000 after buying an additional 851 shares in the last quarter. E. Ohman J or Asset Management AB grew its position in Procter & Gamble by 2.1% in the third quarter. E. Ohman J or Asset Management AB now owns 91,218 shares of the company’s stock valued at $13,252,000 after acquiring an additional 1,900 shares during the period. SBI Securities Co. Ltd. raised its stake in Procter & Gamble by 0.6% during the third quarter. SBI Securities Co. Ltd. now owns 115,968 shares of the company’s stock worth $16,848,000 after acquiring an additional 732 shares in the last quarter. Marion Wealth Management raised its stake in Procter & Gamble by 3.3% during the third quarter. Marion Wealth Management now owns 15,088 shares of the company’s stock worth $2,192,000 after acquiring an additional 486 shares in the last quarter. Finally, Smith Chas P & Associates PA Cpas raised its stake in Procter & Gamble by 2.3% during the third quarter. Smith Chas P & Associates PA Cpas now owns 280,827 shares of the company’s stock worth $44,750,000 after acquiring an additional 6,290 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company’s stock.

Procter & Gamble Trading Down 2.6%

PG stock opened at $161.21 on Friday. The business has a fifty day moving average price of $148.41 and a 200 day moving average price of $147.09. The company has a debt-to-equity ratio of 0.40, a current ratio of 0.72 and a quick ratio of 0.47. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The stock has a market capitalization of $374.43 billion, a price-to-earnings ratio of 24.28, a P/E/G ratio of 4.11 and a beta of 0.39.

Procter & Gamble (NYSE:PG) last posted its quarterly earnings data on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping analysts’ consensus estimates of $1.89 by $0.11. The company had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. Procter & Gamble had a return on equity of 30.91% and a net margin of 18.23%. The business’s revenue was up 4.0% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.99 earnings per share. Analysts expect that Procter & Gamble Company will post 6.98 EPS for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be issued a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date of this dividend is Friday, October 23rd. Procter & Gamble’s payout ratio is currently 65.71%.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Multiple analysts raised targets and maintained bullish ratings. UBS lifted its target to $190 and retained a Buy rating, while Citigroup raised its target to $187, BNP Paribas Exane to $189, and JPMorgan to $180. Freedom Broker also upgraded PG from Hold to Buy with a $176 target. These revisions suggest analysts believe the earnings improvement and resilient demand can support further gains.
• Positive Sentiment: Fiscal Q1 results exceeded expectations. Adjusted EPS was $2.00 versus the $1.89 consensus, while revenue increased 4% year over year to $23.28 billion, topping estimates of approximately $22.80 billion. Organic sales also grew 4%, with volume contributing 2.4 percentage points. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Demand and operating trends remain encouraging. Stronger volumes, favorable product mix, productivity savings, and resilient laundry and home-product sales supported the quarter. Investors also continue to value PG’s defensive business mix and 70-year record of dividend increases. P&G dividend history
• Neutral Sentiment: Fiscal 2027 guidance was mixed. The company raised its all-in sales-growth outlook, partly reflecting the Thorne acquisition, but projected revenue of $86.0 billion to $87.7 billion remains below the roughly $88.8 billion consensus. EPS guidance of $6.89 to $7.11 brackets expectations of $6.98.
• Negative Sentiment: Commodity and energy inflation remain the main risks. Higher oil, raw-material, transportation, and energy costs are expected to create an estimated $1.4 billion headwind and pressure margins. TD Cowen raised its target to $166 but kept a Hold rating, warning that cost inflation could limit the recovery. P&G commodity cost outlook

Insider Buying and Selling at Procter & Gamble

In other Procter & Gamble news, CEO Paul Gama sold 2,225 shares of the firm’s stock in a transaction dated Monday, October 5th. The shares were sold at an average price of $145.34, for a total value of $323,381.50. Following the completion of the sale, the chief executive officer owned 51,124 shares in the company, valued at approximately $7,430,362.16. This trade represents a 4.17% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Susan Whaley sold 2,369 shares of the business’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $344,310.46. Following the completion of the transaction, the insider directly owned 30,730 shares of the company’s stock, valued at approximately $4,466,298.20. This represents a 7.16% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 15,135 shares of company stock worth $2,189,970 over the last quarter. Corporate insiders own 0.23% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on the stock. Freedom Broker upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and set a $176.00 target price on the stock in a research note on Friday. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Procter & Gamble in a report on Friday. Royal Bank Of Canada set a $169.00 target price on shares of Procter & Gamble in a research report on Friday. UBS Group set a $166.00 price target on shares of Procter & Gamble in a report on Friday. Finally, HSBC restated a “hold” rating and issued a $149.00 price target (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Fifteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus target price of $168.90.

About Procter & Gamble

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.